AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Clinical trial NCT06665165 · RECRUITING
Trial details
- NCT number
- NCT06665165
- Sponsor
- Amylyx Pharmaceuticals Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-07
- Primary completion
- 2027-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.